treatment of systemic sclerosis
All entries for: Boehringer Ingelheim Pharmaceuticals
March 9, 2026
Boehringer Ingelheim Pharmaceuticals
Orphan Drug Designation
Disease Area: Rare Diseases
treatment of systemic sclerosis